Quipt Home Medical Corp. Stock

Equities

QIPT

CA74880P1045

Healthcare Facilities & Services

Market Closed - Toronto S.E. 04:00:00 2024-05-17 pm EDT 5-day change 1st Jan Change
4.26 CAD -7.79% Intraday chart for Quipt Home Medical Corp. -22.40% -36.89%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 360M 264M Sales 2025 * 390M 286M Capitalization 181M 133M
Net income 2024 * -2M -1.47M Net income 2025 * 5M 3.67M EV / Sales 2024 * 0.5 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.47 x
P/E ratio 2024 *
-54.4 x
P/E ratio 2025 *
22.9 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.08%
More Fundamentals * Assessed data
Dynamic Chart
Canaccord Genuity Adjusts Price Target on Quipt Home Medical to $8 From $9, Maintains Buy Rating MT
Raymond James Downgrades Quipt Home Medical to Underperform MT
Transcript : Quipt Home Medical Corp., Q2 2024 Earnings Call, May 16, 2024
Quipt Home Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
Quipt Home Medical Corp. Brief: Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue MT
Quipt Home Medical Corp. Brief: Revenue for Q2 2024 was US$64.0 million compared to $58.1 million for Q2 2023, representing a 10% increase MT
Quipt Home Medical Corp. announces an Equity Buyback for 3,626,845 shares, representing 8.52% of its issued share capital. CI
Quipt Home Medical Announces 10% Stock Buyback MT
Quipt Home Medical Corp. authorizes a Buyback Plan. CI
Quipt Home Medical Maintained at Buy at Stifel GMP After Fiscal Q1 Results; Price Target Cut to C$10.50 MT
Transcript : Quipt Home Medical Corp., Q1 2024 Earnings Call, Feb 15, 2024
Quipt Home Medical Corp. Brief: Revenue for Q1 2024 was US$65.4 million compared to $40.8 million for Q1 2023; Net income (loss) for Q1 2024 was $(0.6) million, or ($0.01) per diluted share MT
Quipt Home Medical Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
North American Morning Briefing :Stock Futures -2- DJ
Quipt Home Medical Corp. Brief: Shelf Prospectus and Registration Statement, when made final and effective, will enable Co to offer Up to C$300,000,000 of common shares, preferred shares, debt securities, warrants MT
More news
1 day-7.79%
1 week-22.40%
Current month-14.11%
1 month-11.06%
3 months-29.24%
6 months-38.17%
Current year-36.89%
More quotes
1 week
4.23
Extreme 4.23
5.68
1 month
4.23
Extreme 4.23
5.68
Current year
4.23
Extreme 4.23
6.98
1 year
4.23
Extreme 4.23
8.12
3 years
4.23
Extreme 4.23
9.75
5 years
1.88
Extreme 1.88
10.16
10 years
1.50
Extreme 1.5
10.16
More quotes
Managers TitleAgeSince
Chief Executive Officer - 16-04-18
Director of Finance/CFO - 18-02-14
Chief Tech/Sci/R&D Officer - 09-12-31
Members of the board TitleAgeSince
Chief Executive Officer - 16-04-18
Director/Board Member - 17-12-20
Director/Board Member - 20-12-06
More insiders
Date Price Change Volume
24-05-17 4.26 -7.79% 269,362
24-05-16 4.62 -14.44% 218,127
24-05-15 5.4 -1.82% 36,940
24-05-14 5.5 -0.36% 41,400
24-05-13 5.52 +0.55% 4,612

Delayed Quote Toronto S.E., May 17, 2024 at 04:00 pm EDT

More quotes
Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
4.26 CAD
Average target price
12.67 CAD
Spread / Average Target
+197.34%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW